iQIYI interim CFO amends stock option awards

iQIYI, Inc.’s interim CFO Zeng Ying reported amendments to existing stock option awards rather than open-market trades.

Rhea-AI Filing Summary

iQIYI, Inc.’s interim CFO Zeng Ying reported amendments to existing stock option awards rather than open-market trades. Two fully vested option grants for 700,000 and 480,056 Class A ordinary shares at an exercise price of $0.5119 per share were effectively cancelled and regranted, extending their expiration to October 18, 2030. The filing also shows a separate option position covering 1,050,000 Class A ordinary shares with a zero exercise price expiring on May 11, 2036, giving her a substantial, long-term equity-based incentive.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Zeng Ying Ms.

Role Interim CFO

Type	Security	Shares	Price	Value
Disposition	Option (right to buy)	480,056	$0.00	$0.00
Grant/Award	Option (rignt to buy)	480,056	$0.00	$0.00
Disposition	Option (right to buy)	700,000	$0.00	$0.00
Grant/Award	Option (right to buy)	700,000	$0.00	$0.00
holding	Option (right to buy)	--	--	--

Holdings After Transaction: Option (right to buy) — 1,750,000 contracts for 1,050,000 underlying shares (Direct); Option (rignt to buy) — 480,056 contracts (Direct)

Footnotes (5)

1. F1. The options vest over a four-year period, with 25% vesting on each of the 1st, 2nd, 3rd and 4th anniversary of 05/11/2026.
2. F2. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
3. F3. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030.
4. F4. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.
5. F5. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030.

Key Figures

Amended option grant size: 700,000 options Second amended option grant: 480,056 options Exercise price of amended options: $0.5119 per share +2 more

5 metrics

Amended option grant size 700,000 options Fully vested option deemed cancelled and regranted, expires October 18, 2030

Second amended option grant 480,056 options Fully vested option deemed cancelled and regranted, expires October 18, 2030

Exercise price of amended options $0.5119 per share Applies to both the 700,000 and 480,056 option grants

New expiration date for amended options October 18, 2030 Extended from prior 2027 and 2028 expirations per footnotes

Additional option position 1,050,000 underlying shares Option with $0.0000 exercise price expiring May 11, 2036

Key Terms

Grant, award, or other acquisition, Disposition to issuer, vest over a four-year period, expiration date, +1 more

5 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Disposition to issuer financial

"transaction_code_description: Disposition to issuer"

vest over a four-year period financial

"The options vest over a four-year period, with 25% vesting..."

expiration date financial

"As amended, the options expire on 10/18/2030."

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Class A ordinary share financial

"underlying_security_title: Class A ordinary share"

A Class A ordinary share is a type of common stock a company issues that carries a specific set of rights—most often particular voting power, dividend terms, or transfer rules—distinct from other share classes. For investors it matters because those rights affect control over company decisions, how income is paid out, and how easy shares are to buy or sell; think of it like a tiered ticket that gives different access and influence at the same event.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does iQIYI (IQ) interim CFO Zeng Ying’s latest Form 4 report?

The Form 4 reports amendments to Zeng Ying’s stock option awards. Existing fully vested options were cancelled and replaced with new options on identical share amounts but later expiration dates, updating her long-term equity compensation without any open-market share purchases or sales.

How many iQIYI options were affected in Zeng Ying’s Form 4 filing?

Two fully vested option awards were affected: one for 700,000 Class A ordinary shares and another for 480,056 shares. Each award was deemed cancelled and regranted with a new expiration date, keeping the same underlying share counts while updating contractual terms.

What exercise price applies to the amended iQIYI options in this Form 4?

The amended option awards have an exercise price of $0.5119 per Class A ordinary share. This price applies to both the 700,000-share grant and the 480,056-share grant, which replaced older options that previously would have expired in 2027 and 2028, respectively.

When do the iQIYI options reported for Zeng Ying now expire?

The two amended option awards now expire on October 18, 2030. In addition, the filing shows a separate option position over 1,050,000 Class A ordinary shares with a zero exercise price that is scheduled to expire on May 11, 2036, extending her potential ownership horizon.

Were these iQIYI Form 4 transactions open-market buys or sells of stock?

No, the transactions involve option grants and cancellations with the issuer, not open-market trades. Codes and descriptions show grant or award acquisitions and dispositions to the issuer, reflecting compensation-related updates instead of direct purchases or sales of common shares in the market.

How do the vesting terms work for the iQIYI options in this Form 4?

Footnotes state the affected options vest over four years, with 25% vesting on the first anniversary and the remaining 75% vesting in 12 equal quarterly installments. Some referenced options are already fully vested, meaning only their expiration dates, not vesting schedules, were changed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 08:30 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zeng Ying Ms.

(Last) (First) (Middle)

4F, IQIYI YOUTH CENTER, YOOLEE PLAZA,

NO. 21 NORTH ROAD OF WORKERS' STADIUM

(Street)

BEIJING CHINA 100027

(City) (State) (Zip)

CHINA

(Country)

2. Issuer Name and Ticker or Trading Symbol
iQIYI, Inc. [ IQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	$0							(1)	05/11/2036	Class A ordinary share	1,050,000		1,050,000	D
Option (right to buy)	$0.5119	05/11/2026		D			480,056	(2)	02/14/2027	Class A ordinary share	480,056	(3)	0	D
Option (rignt to buy)	$0.5119	05/11/2026		A		480,056		(2)	10/18/2030	Class A ordinary share	480,056	(3)	480,056	D
Option (right to buy)	$0.5119	05/11/2026		D			700,000	(4)	02/28/2028	Class A ordinary share	700,000	(5)	0	D
Option (right to buy)	$0.5119	05/11/2026		A		700,000		(4)	10/18/2030	Class A ordinary share	700,000	(5)	700,000	D

Explanation of Responses:

1. The options vest over a four-year period, with 25% vesting on each of the 1st, 2nd, 3rd and 4th anniversary of 05/11/2026.

2. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/14/2017, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.

3. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/14/2027) and grant of new options. As amended, the options expire on 10/18/2030.

4. The options have fully vested over a four-year period, with 25% vested on the 1st anniversary of 02/28/2018, and the remaining 75% vested in 12 equal quarterly installments beginning one calendar quarter after the date of the aforesaid anniversary.

5. The two reported transactions involved an amendment of outstanding options to extend the expiration date, which may be deemed a cancellation of the original options (to expire on 02/28/2028) and grant of new options. As amended, the options expire on 10/18/2030.

	/s/ Zeng Ying	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)